Xia Zhang Selected Research

Reperfusion Injury

1/2023	Podoplanin: A potential therapeutic target for thrombotic diseases.
4/2022	Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis.
11/2019	Evaluating the Protective Effects of Mitochondrial Glutathione on Cerebral Ischemia/Reperfusion Injury via Near-Infrared Fluorescence Imaging.
8/2019	HMGB1/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia/reperfusion injury.
3/2015	Poly (I:C) therapy decreases cerebral ischaemia/reperfusion injury via TLR3-mediated prevention of Fas/FADD interaction.
6/2014	MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6.
4/2014	The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xia Zhang Research Topics

Disease

215	Neoplasms (Cancer) 04/2024 - 02/2002
38	Inflammation (Inflammations) 05/2024 - 02/2004
34	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2005
34	Infections 11/2022 - 08/2003
31	Glioma (Gliomas) 04/2024 - 10/2004
26	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2002
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 05/2012
22	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 06/2005
22	Type 2 Diabetes Mellitus (MODY) 01/2024 - 06/2009
20	Stomach Neoplasms (Stomach Cancer) 08/2022 - 03/2007
19	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2003
17	Pain (Aches) 05/2024 - 03/2012
15	Ischemic Stroke 06/2023 - 11/2013
15	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 12/2003
14	Carcinogenesis 01/2024 - 05/2012
14	Tuberculosis (Tuberculoses) 01/2024 - 02/2013
14	Body Weight (Weight, Body) 01/2024 - 03/2008
14	Stroke (Strokes) 06/2023 - 04/2004
13	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2014
12	Hemorrhage 01/2023 - 02/2011
12	Insulin Resistance 02/2022 - 06/2009
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2023 - 09/2012
11	Sepsis (Septicemia) 10/2022 - 08/2012
11	Adenocarcinoma of Lung 08/2021 - 05/2013
10	Hypoxia (Hypoxemia) 04/2024 - 08/2013
10	COVID-19 03/2024 - 01/2020
10	Hypertension (High Blood Pressure) 11/2023 - 01/2010
10	Carcinoma (Carcinomatosis) 01/2022 - 02/2002
9	Pneumonia (Pneumonitis) 11/2023 - 01/2015
9	Fibrosis (Cirrhosis) 07/2023 - 12/2012
8	Brain Ischemia (Cerebral Ischemia) 03/2022 - 08/2005
7	Wounds and Injuries (Trauma) 03/2024 - 01/2008
7	Disease Progression 01/2024 - 01/2007
7	Cognitive Dysfunction 05/2023 - 08/2005
7	Reperfusion Injury 01/2023 - 04/2014
7	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 11/2003
7	Lymphatic Metastasis 01/2022 - 06/2014
7	Adenocarcinoma 01/2021 - 08/2008
7	Seizures (Absence Seizure) 12/2020 - 07/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 07/2010
7	Leukemia 09/2017 - 10/2004
6	Pulmonary Tuberculosis 05/2024 - 08/2006
6	Myocardial Infarction 02/2024 - 03/2013
6	Necrosis 02/2024 - 08/2003
6	Neuroinflammatory Diseases 01/2024 - 01/2013
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 02/2015
6	Hypoglycemia (Reactive Hypoglycemia) 04/2023 - 01/2020
6	Colonic Neoplasms (Colon Cancer) 01/2023 - 05/2013

Drug/Important Bio-Agent (IBA)

71	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2003
49	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2003
35	Messenger RNA (mRNA)IBA 01/2023 - 03/2004
24	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2006
20	CytokinesIBA 02/2024 - 11/2004
17	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2004
16	HLA-G Antigens (HLA G)IBA 08/2022 - 09/2010
15	RNA (Ribonucleic Acid)IBA 02/2024 - 05/2010
15	Therapeutic UsesIBA 07/2022 - 02/2004
14	Long Noncoding RNAIBA 05/2024 - 01/2015
14	MicroRNAs (MicroRNA)IBA 12/2023 - 06/2009
14	LigandsIBA 01/2023 - 07/2003
12	Insulin (Novolin)FDA Link 01/2024 - 02/2003
11	Transcription Factors (Transcription Factor)IBA 01/2024 - 03/2009
11	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 03/2003
11	Interleukin-2 (IL2)IBA 01/2022 - 08/2003
10	EnzymesIBA 03/2023 - 05/2004
10	Small Interfering RNA (siRNA)IBA 04/2021 - 10/2004
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 07/2003
9	AntioxidantsIBA 01/2024 - 11/2013
9	Analgesics (Analgesic Drugs)IBA 01/2023 - 07/2009
9	AntigensIBA 01/2023 - 08/2003
9	Immunoglobulin G (IgG)IBA 01/2023 - 04/2011
9	HLA Antigens (Human Leukocyte Antigens)IBA 08/2022 - 09/2010
9	Cisplatin (Platino)FDA LinkGeneric 06/2020 - 11/2008
8	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 12/2012
8	Peptides (Polypeptides)IBA 11/2022 - 11/2003
8	Estrogen ReceptorsIBA 07/2022 - 07/2005
8	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 11/2008
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2013
7	CateninsIBA 04/2023 - 05/2013
7	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2014
7	LipidsIBA 03/2021 - 04/2004
7	Oxygen (Dioxygen)IBA 02/2021 - 08/2012
7	AdiponectinIBA 01/2019 - 06/2009
6	VaccinesIBA 03/2024 - 09/2007
6	InterleukinsIBA 01/2024 - 11/2004
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2023 - 07/2009
6	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2020
6	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2023 - 07/2010
6	Interleukin-6 (Interleukin 6)IBA 03/2023 - 06/2009
6	ORALIT (ORS)IBA 01/2023 - 01/2012
6	CholesterolIBA 12/2022 - 07/2009
6	salicylhydroxamic acid (SHAM)IBA 10/2022 - 06/2012

Therapy/Procedure

95	Therapeutics 05/2024 - 02/2004
34	Drug Therapy (Chemotherapy) 01/2024 - 02/2002
20	Immunotherapy 12/2023 - 03/2015
13	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2023 - 11/2012
10	Ligation 10/2022 - 01/2008
8	Radiotherapy 08/2023 - 01/2008
7	Punctures 10/2022 - 08/2012
6	Transplantation 01/2023 - 09/2018